Planned Rule 144 sale of 1,464 common shares

A holder of IDXX common stock has filed a Rule 144 notice to sell 1,464 shares through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $920,293.11.

Rhea-AI Filing Summary

A holder of IDXX common stock has filed a Rule 144 notice to sell 1,464 shares through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $920,293.11. Shares of common stock outstanding were 79,851,330 as of the filing.

The shares to be sold were acquired through restricted stock grants of 257 shares on 05/06/2024 and 262 shares on 05/06/2025, and a stock option exercise of 945 shares for cash on 02/17/2026, all from the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for IDXX disclose?

The Form 144 filing discloses a planned sale of 1,464 common shares of IDXX under Rule 144. The shares will be sold on the NASDAQ through Morgan Stanley Smith Barney LLC with an aggregate market value of $920,293.11.

How many IDXX shares are planned to be sold and at what value?

The notice covers a proposed sale of 1,464 IDXX common shares with an aggregate market value of $920,293.11. This planned sale is to be executed on the NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

How were the IDXX shares in this Form 144 acquired?

The securities were acquired via restricted stock and a stock option exercise. The holder received 257 shares on 05/06/2024 and 262 shares on 05/06/2025 as restricted stock, plus 945 shares on 02/17/2026 through a cash stock option exercise.

What is the role of Morgan Stanley in the IDXX Form 144 filing?

Morgan Stanley Smith Barney LLC Executive Financial Services is listed as the broker for the Rule 144 sale. The firm will handle the sale of 1,464 IDXX common shares on the NASDAQ on or about 02/17/2026, per the notice.

How many IDXX shares were outstanding when this Form 144 was filed?

The filing states that 79,851,330 common shares of IDXX were outstanding. This figure provides context for the planned Rule 144 sale of 1,464 shares, showing the transaction’s size relative to the total share count.

Does the Form 144 filer claim to have undisclosed adverse information on IDXX?

The person for whose account the securities will be sold represents that they do not know any material adverse information about IDXX’s current or prospective operations that has not been publicly disclosed, as required by the Rule 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 04:25 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001442078
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IDEXX LABORATORIES, INC.
SEC File Number	000-19271
Address of Issuer	One IDEXX Drive Westbrook MAINE 04092
Phone	207-556-0300
Name of Person for Whose Account the Securities are To Be Sold	SOPHIE V VANDEBROEK
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1464	920293.11	79851330	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/06/2024	Restricted Stock	Issuer			257	05/06/2024	Not Applicable
Common	05/06/2025	Restricted Stock	Issuer			262	05/06/2025	Not Applicable
Common	02/17/2026	Stock Option Exercise	Issuer			945	02/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Sophie V. Vandebroek
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)